CSBR

Champions Oncology (CSBR)

About Champions Oncology (CSBR)

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Details

Daily high

$7.66

Daily low

$7.15

Price at open

$7.64

52 Week High

$7.85

52 Week Low

$3.60

Market cap

103.7M

Dividend yield

0.00%

Volume

119,179

Avg. volume

64,620

P/E ratio

-154.11

Champions Oncology News